Marksans Pharma Limited
NSE: MARKSANS.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Mark Saldanha
- Employees
- 1,141
- Headquarters
- Mumbai, India
- IPO year
- 2002
- Market cap
- ₹89.6B
- Website
- https://marksanspharma.com
Loading MARKSANS…
Loading profile data…Frequently asked questions about MARKSANS
What does Marksans Pharma Limited (MARKSANS.NS) do?
Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes,...
Where does MARKSANS.NS trade?
Marksans Pharma Limited (MARKSANS.NS) trades on the National Stock Exchange of India.
What sector is MARKSANS.NS in?
Marksans Pharma Limited (MARKSANS.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Marksans Pharma Limited?
Mark Saldanha is the chief executive officer of Marksans Pharma Limited (MARKSANS.NS).
Where is Marksans Pharma Limited headquartered?
Marksans Pharma Limited is headquartered in India.
Does MARKSANS.NS pay a dividend?
Yes — Marksans Pharma Limited (MARKSANS.NS) paid a trailing twelve-month dividend of INR 0.80 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did MARKSANS.NS go public?
Marksans Pharma Limited (MARKSANS.NS) completed its initial public offering in 2002.